4.2% Sales Growth
KLBF posted the growth of 4.2% in sales from IDR4.82 trilion in 3Q16 into IDR5.02 trillion in 3Q17. The nutritional food division posting the growth of 9% and the prescription drugs division posting the growth of 8% were the bolster for the growth in sales.
Slight Growth of 1.2% in Net Profit
KLBF booked the net profit nudging up 1.2% from IDR556 billion in 3Q16 into IDR563 billion 3Q17. It succeeded to maintain the stable gross profit margin for its four business divisions. The nutritional food, prescription drugs, and consumer health divisions have the gross profit margin at the average of 56%, while the distribution & packaging division has the gross profit margin at the average of 30%.
Download full report HERE.
